Clinical Trials Directory

Trials / Unknown

UnknownNCT03421314

Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.

Effect of Zinc and Selenium Supplementation on Clinical and Immunological Parameters on HIV+ Individuals on Antiretroviral Treatment.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
37 (estimated)
Sponsor
Instituto Nacional de Enfermedades Respiratorias · Other Government
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effect of zinc gluconate and/or selenium yeast supplementation during six months on clinical (glucose, cholesterol, triglycerides, bone mineral density and body composition) and immunological (oxidative stress, CD4+ count and pro-inflammatory cytokines) parameters in a population with HIV diagnosis on antiretroviral treatment.

Detailed description

HIV-infected individuals on antiretroviral treatment have lowest risk of AIDS events and more life expectancy. However, antiretroviral treatment does not fully restore the immune system in all individuals due to persistent immune activation and inflammation, increasing the risk of non-AIDS complications, such as insulin resistance, diabetes, hypertension, dyslipidemia, obesity, low bone mass density, oxidative stress and micronutrient deficiencies. Several studies showed that HIV+ patients present zinc and selenium deficiency. Those micronutrients are involved in the pathogenesis of metabolic complications and have a major role in maintaining immune system function. It remains unknown the effect of zinc and selenium supplementation on metabolic and immunological parameters associated to non-AIDS complications.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTZinc gluconate and/or Selenium yeast30 mg dose of zinc gluconate and/or 200 mcg of selenium yeast

Timeline

Start date
2016-09-01
Primary completion
2019-12-31
Completion
2020-01-01
First posted
2018-02-05
Last updated
2019-01-30

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03421314. Inclusion in this directory is not an endorsement.